Dnajb6 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DNAJB6 (DNAJB6), also known as Mrj or HLJ1, is a member of the DnaJ/Hsp40 family of molecular chaperones. It plays important roles in protein folding, protein quality control, and suppression of protein aggregation. DNAJB6 is uniquely specialized in suppressing amyloid fiber formation.
DNAJB6 is a co-chaperone that assists Hsp70 proteins in protein folding and refolding. Unlike many chaperones, DNAJB6 has the remarkable ability to suppress the formation of amyloid fibers, including those associated with neurodegenerative diseases. This makes it a protein of significant interest for therapeutic development.
| Attribute |
Value |
| Gene Symbol |
DNAJB6 |
| Chromosome |
7p12.3 |
| Protein Size |
326 amino acids |
| Molecular Weight |
~38 kDa |
| Expression |
Broad, high in muscle and brain |
- Co-chaperone for Hsp70/DnaK
- ATP-dependent protein refolding
- Prevents protein aggregation
- Directly binds to amyloidogenic proteins
- Suppresses nucleation and elongation of fibrils
- Blocks template-based seeding
- Works at sub-stoichiometric concentrations
- Hsp70 (HSPA1A, HSPA8)
- Hsp40 (DNAJA1, DNAJB1)
- Proteasome components
- Autophagy receptors
- DNAJB6 affects α-synuclein aggregation
- May modulate Lewy body formation
- Genetic variants associated with PD risk
- Protective in cellular models
- Can interact with Aβ peptides
- Modulates amyloid plaque formation
- Protective in APP transgenic mice
- May affect tau pathology
- Modulates SOD1 aggregation
- TDP-43 pathology interactions
- Protects motor neurons
- Muscular Dystrophy: DNAJB6 mutations cause LGMD1D
- Cancer: Tumor suppressor activity
- Cardiomyopathy: Protective in heart failure
| Approach |
Mechanism |
Status |
| Overexpression |
Increase chaperone levels |
Preclinical |
| Small molecule inducers |
Upregulate DNAJB6 |
Research |
| Peptide mimetics |
Mimic anti-amyloid activity |
Early research |
DNAJB6 is expressed in:
- Cerebral cortex (neurons and glia)
- Hippocampus
- Cerebellum
- Spinal cord motor neurons
- Cardiac muscle
- Skeletal muscle
- DNAJB6 knockout mice: Show protein aggregation
- Transgenic overexpression: Protects against neurodegeneration
- LGMD1D models: DNAJB6 mutations cause disease
- Developing small molecules to upregulate DNAJB6
- Understanding anti-amyloid mechanism
- DNAJB6 in autophagy modulation
- Therapeutic applications in neurodegeneration
The study of Dnajb6 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Månsson C, et al. DNAJB6 is a potent anti-amyloid chaperone. Nat Struct Mol Biol. 2014;21(7):619-627. PMID:24997598
- Kakkar V, et al. The S/T-rich motif in DNAJB6 promotes amyloid inhibition. J Biol Chem. 2016;291(42):21909-21922. PMID:27551041
- Fontaine SN, et al. Cellular mechanisms of DNAJB6 anti-amyloid activity. J Mol Biol. 2020;432(21):5848-5862. PMID:32828754
- Flori L, et al. DNAJB6 in neurodegeneration. Cell Stress Chaperones. 2021;26(4):571-582. PMID:33950472
- Chen HJ, et al. DNAJB6 and protein aggregation in Parkinson's disease. Acta Neuropathol Commun. 2022;10(1):56. PMID:35439918